Medilloyd Medicament Private Limited - Company Profile

It is a pharma private limited company based in Cuttack, Orissa, India, established in 2012.
2012 Cuttack, Orissa, India Under Cirp
Last Updated:
Access Report
About Medilloyd Medicament Private Limited

Medilloyd Medicament Private Limited, a under cirp private limited company, was established on 20 April 2012 in Cuttack, Orissa, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230OR2012PTC015269. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.

It upholds a compliant status. Its leadership includes Subhalaxmi Jena (Director), Shiba Prasanna Jena (Managing Director). Past directors included Jayant Kumar Patnaik. It holds ₹6.85 Cr open charges and ₹2.70 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Side Lane Of Sbi, Hyderabad Kanika Chhak, Tulsipur, Cuttack, Orissa, 753008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230OR2012PTC015269

  • Registration Number

    015269

  • Incorporation Date

    20 April 2012

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹1.00 Cr

  • ROC Code

    Roc Cuttack

  • Listing Status

    Unlisted

  • Company Status

    Under Cirp

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 13 Year, 9 Months
  • Last Filing with ROC 31 Mar 2020
  • Open Charges ₹ 6.85 Cr
  • Satisfied Charges ₹ 2.70 Cr
  • Revenue Growth **** 11.49%
  • Profit Growth **** -8.07%
  • Ebitda **** 1.52%
  • Net Worth 5.05%
  • Total Assets -9.49%
Company report

Medilloyd Medicament Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medilloyd Medicament Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Medilloyd Medicament Private Limited?
Current Directors
Name Designation Appointment Date Status
Subhalaxmi Jena Director 20 Apr 2012 Current
Shiba Prasanna Jena Managing Director 20 Apr 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Aug 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medilloyd Medicament.

Medilloyd Medicament Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.49% increase. The company also saw a slight decrease in profitability, with a 8.07% decrease in profit. The company's net worth moved up by a moderate rise of 5.05%.

Medilloyd Medicament revenue growth over time
Medilloyd Medicament profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 11.49%
*******
*******
*******
*******
Revenue from Operations
*******
 11.52%
*******
*******
*******
*******
Total Assets
*******
 -9.49%
*******
*******
*******
*******
Profit or Loss
*******
 -8.07%
*******
*******
*******
*******
Net Worth
*******
 5.05%
*******
*******
*******
*******
EBITDA
*******
 1.52%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medilloyd Medicament?

In 2020, Medilloyd Medicament had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹68,500,000.00

Satisfied Charges

₹27,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 4.10 Cr
  • Dcb Bank Limited : 2.75 Cr
Latest Charge Details
Date Lender Amount Status
28 Mar 2017 Others ₹4.10 Cr Open
24 Sep 2015 Dcb Bank Limited ₹2.75 Cr Open
24 Feb 2014 Canara Bank ₹2.70 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Medilloyd Medicament?

Unlock and access historical data on people associated with Medilloyd Medicament, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medilloyd Medicament, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilloyd Medicament's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medilloyd Medicament
Recent Activity within the Organization
  • Annual General Meeting

    The activity Medilloyd Medicament Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.

  • Charges

    A charge with Others of Rs. 4.10 Cr registered on 28 Mar 2017 with Charge ID 100093459 was modified on 05 Aug 2020. was recorded as a recent event.

  • Balance Sheet

    Progress on Medilloyd Medicament Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Cuttack. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 4.10 Cr with Charge ID 100093459 was registered on 28 Mar 2017. was completed.

  • Charges

    The activity A charge registered on 24 Feb 2014 via Charge ID 10487845 with Canara Bank was fully satisfied on 20 Feb 2017. was completed.

  • Charges

    The activity A charge with Dcb Bank Limited amounted to Rs. 2.75 Cr with Charge ID 10608189 was registered on 24 Sep 2015. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medilloyd Medicament Private Limited?

The CIN of Medilloyd Medicament Private Limited is U24230OR2012PTC015269.

Where is Medilloyd Medicament Private Limited headquartered?

Medilloyd Medicament Private Limited is headquartered at Side Lane Of Sbi, Hyderabad Kanika Chhak, Tulsipur, Cuttack, Orissa, 753008.

When was Medilloyd Medicament Private Limited incorporated?

Medilloyd Medicament Private Limited was incorporated on 20 April 2012.

Who are the current directors of Medilloyd Medicament Private Limited?

The current directors of Medilloyd Medicament Private Limited are

What is the primary industry of Medilloyd Medicament Private Limited?

The primary industry of Medilloyd Medicament Private Limited is Trade.

Is Medilloyd Medicament Private Limited a listed company?

Medilloyd Medicament Private Limited is unlisted.

What is the capital structure of Medilloyd Medicament Private Limited?

The authorized capital of Medilloyd Medicament Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.

What is the compliance status of Medilloyd Medicament Private Limited?

The compliance status of Medilloyd Medicament Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available